Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16694832 | 0.98 | ABCB1 (0.41) | ABCB1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL16626228 | 0.93 | ABCB1 (0.39) | ABCB1SMN1; SMN2LMNANPSR1SIGMAR1 | |
| SCHEMBL17240346 | 0.91 | ABCB1 (0.37) | ABCB1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL11954834 | 0.91 | ABCB1 (0.40) | ABCB1SMN1; SMN2LMNANPSR1SIGMAR1 | |
| SCHEMBL17244833 | 0.89 | ABCB1 (0.38) | ABCB1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL2709792 | 0.87 | HPGD (0.42) | ABCB1SMN1; SMN2LMNAHPGDPOLB | |
| SCHEMBL17529732 | 0.85 | ABCB1 (0.46) | ABCB1SMN1; SMN2CA12CA1CA2 | |
| SCHEMBL21331833 | 0.85 | HTR1A (0.41) | ABCB1SMN1; SMN2CA1CA2CA7 | |
| SCHEMBL21331777 | 0.85 | SMN1; SMN2 (0.43) | ABCB1SMN1; SMN2LMNAHPGD | |
| SCHEMBL16162353 | 0.83 | GAA (0.42) | ABCB1SMN1; SMN2LMNASIGMAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114270556-B | Organic photoelectric conversion material | 住友化学株式会社 | 2024-03-29 | — | — | CN | disclosed |
| CN-110741028-B | Method for producing polymer compound | 住友化学株式会社 | 2022-05-03 | — | — | CN | disclosed |
| CN-114270556-A | Organic photoelectric conversion material | 住友化学株式会社 | 2022-04-01 | — | — | CN | disclosed |
| EP-2990113-B1 | METHOD FOR PRODUCING CATALYST FOR CYCLIC CARBONATE SYNTHESIS | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| EP-2990112-B1 | METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE | MARUZEN PETROCHEM CO LTD (JP) | 2020-03-25 | — | — | EP | disclosed |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-24 | — | — | US | disclosed |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-9834536-B2 | Method for producing catalyst for cyclic carbonate synthesis | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2017-12-05 | — | — | US | disclosed |
| WO-2017093149-A1 | Process for the Catalytic Reversible Alkene-Nitrile Interconversion | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2017-06-08 | — | — | WO | disclosed |
| EP-2492274-B1 | 2,4,6- OR 2,6-ALKOXYPHENYL DIALKYLPHOSPHINE, TETRAFLUOROBORATE AND USE THEREOF | UNIV ZHEJIANG (CN) | 2016-09-21 | — | — | EP | disclosed |
| US-20090221820-A1 | Ligands for Transition-Metal-Catalyzed Cross-Couplings, and Methods of Use Thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090221820-A1 | Ligands for Transition-Metal-Catalyzed Cross-Couplings, and Methods of Use Thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-09-03 | — | — | US | disclosed |
| WO-2009085185-A1 | FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INHIBITORS | AMGEN INC. (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2009076622-A2 | LIGANDS FOR TRANSITION-METAL-CATALYZED CROSS-COUPLINGS, AND METHODS OF USE THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-06-18 | — | — | WO | disclosed |
| US-20090099173-A1 | Pyridopyridazine compounds, compositions and methods of use | AMGEN INC. (US) | 2009-04-16 | — | — | US | disclosed |
| US-20090099173-A1 | Pyridopyridazine compounds, compositions and methods of use | AMGEN INC. (US) | 2009-04-16 | — | — | US | disclosed |
| WO-2009035568-A1 | ANNELATED PYRIDAZINES FOR THE TREATMENT OF TUMORS DRIVEN BY INAPPROPRIATE HEDGEHOG SIGNALLING | AMGEN INC. (US) | 2009-03-19 | — | — | WO | disclosed |
| US-20090048259-A1 | Phthalazine compounds, compositions and methods of use | AMGEN INC. (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090048259-A1 | Phthalazine compounds, compositions and methods of use | AMGEN INC. (US) | 2009-02-19 | — | — | US | disclosed |
| WO-2009002469-A1 | PHTHALAZINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | AMGEN INC. (US) | 2008-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048259-A1 | Phthalazine compounds, compositions and methods of use | VHL, HDAC5, SUZ12 | ABCB1 351/4885SMN1; SMN2 2098/4885CA12 154/4885 |
| US-20090099173-A1 | Pyridopyridazine compounds, compositions and methods of use | DPYD, CYP3A5, PNPO | ABCB1 49/4885SMN1; SMN2 1941/4885CA12 1899/4885 |
| US-10029241-B2 | Method for producing catalyst for cyclic carbonate synthesis | CYCS, CA7, CA9 | ABCB1 4857/4885SMN1; SMN2 4667/4885CA12 5/4885 |
| US-10011621-B2 | Method for producing silica gel-immobolized phosphonium salt catalysts | SIK2, SIK3, SIK1 | ABCB1 3878/4885SMN1; SMN2 4562/4885CA12 252/4885 |
| US-20090221820-A1 | Ligands for Transition-Metal-Catalyzed Cross-Couplings, and Methods of Use Thereof | SOD1, TIMCC, TST | ABCB1 4560/4885SMN1; SMN2 3652/4885CA12 566/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.